SCHEMBL7300790

SCHEMBL7300790

Cc1nnc(COc2ccc3ccc(=O)oc3c2)s1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.57
ALDH1A1 P00352 3/20 0.57
LMNA P02545 1/20 0.57
CA12 O43570 8/20 0.57
CA1 P00915 8/20 0.57
CA9 Q16790 8/20 0.57
CA6 P23280 5/20 0.57
CA7 P43166 5/20 0.57
CA14 Q9ULX7 5/20 0.57
CA4 P22748 5/20 0.57
CA5B Q9Y2D0 3/20 0.57
CA5A P35218 3/20 0.57
CYP1A2 P05177 1/20 0.57
NPC1 O15118 3/20 0.56
RAB9A P51151 2/20 0.56
CA2 P00918 3/20 0.55
MAOB P27338 3/20 0.55
CA3 P07451 3/20 0.55
MAOA P21397 2/20 0.55
MTNR1A P48039 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7293972 0.86 MAOB (0.56) CA12CA1CA7CA4CA5B
SCHEMBL7296443 0.84 ALDH1A1 (0.64) KDM4EALDH1A1CA12CA1CA7
SCHEMBL7302123 0.80 MAOB (0.77) MAOBMAOA
SCHEMBL7297386 0.79 AR (0.66) MAOB
SCHEMBL7292938 0.78 MAOB (0.67) KDM4EALDH1A1LMNACA12CA9
SCHEMBL7293827 0.76 MAOB (0.65) KDM4EALDH1A1LMNACA12CA1
SCHEMBL7294868 0.75 MAOB (0.64) KDM4EALDH1A1NPC1RAB9AMAOB
SCHEMBL7291407 0.75 MAOB (0.64) KDM4EALDH1A1MAOBMAOAHPGD
SCHEMBL7300401 0.75 TDP1 (0.62) KDM4EALDH1A1RAB9AMAOBMEN1
Ethoxycoumarin SCHEMBL119072 0.73 CA9 (1.00) KDM4EALDH1A1CA12CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0363796-B1 HETEROCYCLICALLY SUBSTITUTED ALKOXYCOUMARINES, METHOD FOR THEIR PREPARATION AND THERAPEUTICAL AGENTS CONTAINING SAME BASF Aktiengesellschaft (DE) 1993-08-11 EP disclosed
US-5227392-A Monoamine oxidase inhibitors BASF AKTIENGESELLSCHAFT (DE) 1993-07-13 US disclosed
US-5073563-A Enzyme inhibitors, CNS BASF AKTIENGESELLSCHAFT (DE) 1991-12-17 US disclosed
EP-0363796-A1 Heterocyclically substituted alkoxycoumarines, method for their preparation and therapeutical agents containing same BASF Aktiengesellschaft (DE) 1990-04-18 EP disclosed